Genotype distributions in top-level soccer players: A role for ace ?

International Journal of Sports Medicine

Volumn 30, Issue 5, 2009, Pages 387-392

  Juffer, P ^a   Furrer, R ^a   Gonzalez Freire M ^a   Santiago, C ^a   Verde, Z ^a   Serratosa, L ^b   Morate, F J ^b   Rubio, J C ^c   Martin, M A ^c   Ruiz, J R ^d   Arenas, J ^c   Gomez Gallego F ^a   Lucia, A ^a  

^a UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^b Medicina de la Educación Física y el Deporte   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

AMPD1; Endurance; GDF 8; Genetics; Myostatin; Power; Sports

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE 1; DIPEPTIDYL CARBOXYPEPTIDASE; MYOSTATIN; PEPTIDE HYDROLASE; UNCLASSIFIED DRUG; ADENOSINE MONOPHOSPHATE DEAMINASE; AMPD1 PROTEIN, HUMAN;

ADULT; ARTICLE; ATHLETE; ATHLETIC PERFORMANCE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MALE; MUSCLE MASS; MUSCLE STRENGTH; PHENOTYPE; SITTING; SPORT; TRAINING; ADOLESCENT; ALLELE; ENDURANCE; GENETICS; PHYSIOLOGY; RUNNING;

ADOLESCENT; ADULT; ALLELES; AMP DEAMINASE; ATHLETIC PERFORMANCE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MUSCLE STRENGTH; MYOSTATIN; PEPTIDYL-DIPEPTIDASE A; PHYSICAL ENDURANCE; POLYMORPHISM, GENETIC; RUNNING; SOCCER; YOUNG ADULT;

EID: 67650293221     PISSN: 01724622     EISSN: 14393964     Source Type: Journal    
DOI: 10.1055/s-0028-1105931     Document Type: Article

References (47)

1. Ascensao A, Rebelo A, Oliveira E, Marques F, Pereira L, Magalhaes J. Biochemical impact of a soccer match analysis of oxidative stress and muscle damage markers throughout recovery. Clin Biochem 2008 41 841-851
2. Bangsbo J. Energy demands in competitive soccer. J Sports Sci 1994 12 S5-S12
3. Bangsbo J, Norregaard, L, Thorso F. Activity profile of competition soccer. Can J Sports Sci 1991 16 110-116
4. Cam S, Colakoglu M, Colakoglu S, Sekuri C, Berdeli A. ACE I/D gene polymorphism and aerobic endurance development in response to training in a non-elite female cohort. J Sports Med Phys Fitness 2007 47 234-238
5. Casajús JA. Seasonal variation in fitness variables in professional soccer players. J Sports Med Phys Fitness 2001 41 463-469
6. Chang YF, Imam JS, Wilkinson MF. The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem 2007 76 51-74
7. Cometti G, Maffiuletti NA, Pousson M, Chatard JC, Maffulli N. Isokinetic strength and anaerobic power of elite, subelite and amateur French soccer players. Int J Sports Med 2001 22 45-51
8. Day SH, Gohlke P, Dhamrait SS, Williams AG. No correlation between circulating ACE activity and VO2max or mechanical efficiency in women. Eur J Appl Physiol 2007 99 11-18
9. Ekblom B. Applied physiology of soccer. Sports Med 1986 3 50-60
10. Ergün M, Ilegen C, Takiran E. A cross-sectional analysis of sagittal knee laxity and isokinetic muscle strength in soccer players. Int J Sports Med 2004 25 594-598
11. Ferrell RE, Conte V, Lawrence EC, Roth SM, Hagberg JM, Hurley BF. Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes. Genomics 1999 62 203-207
12. Fischer H, Esbjörnsson M, Sabina RL, Strömberg A, Peyrard-Janvid M, Norman B. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects. J Appl Physiol 2007 103 315-322
13. Giaccaglia V, Nicklas B, Kritchevsky S, Mychalecky J, Messier S, Bleecker E, Pahor M. Interaction between angiotensin converting enzyme insertion/deletion genotype and exercise training on knee extensor strength in older individuals. Int J Sports Med 2008 29 40-44
14. Gonzalez-Freire M, Santiago S, Verde Z, Lao JI, Olivan J, Gómez-Gallego F, Lucia A. Unique among unique. Is it genetically determined? Br J Sports Med [in press, 2008]
15. Hunley TE, Julian BA, Phillips JA, Summar ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon V. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996 49 571-577
16. Huygens W, Thomis MA, Peeters MW, Aerssens MW, Janssen R, Vlietinck RF, Beunen G. Linkage of myostatin pathway genes with knee strength in humans. Physiol Genomics 2004 17 264-270
17. Jones A, Montgomery HE, Woods DR. Human performance: a role for the ACE genotype? Exerc Sport Sci Rev 2002 30 184-190 (Pubitemid 35204534)
18. Jones A, Woods DR. Skeletal muscle RAS and exercise performance. Int J Biochem Cell Biol 2003 35 855-866
19. Kirkendall DT. The applied sport science of soccer. Physician Sportsmed 1985 13 53-59
20. Lazarim FL, Antunes-Neto JM, da Silva FO, Nunes LA, Bassini-Cameron A, Cameron LC, Alves AA, Brenzikofer R, de Macedo DV. The upper values of plasma creatine kinase of professional soccer players during the Brazilian National Championship. J Sci Med Sport 2008 [Epub ahead of print]
21. Little T, Williams AG. Specificity of acceleration, maximal speed, and agility in professional soccer players. J Strength Cond Res 2005 19 76-78
22. Lowenstein JM. Ammonia production in muscle and other tissues: the purine nucleotide cycle. Physiol Rev 1972 52 382-414
23. Lucia A, Gomez-Gallego F, Santiago C, Bandres F, Earnest C, Rabadan M, Alonso JM, Hoyos J, Cordova A, Villa G, Foster C. ACTN3 Genotype in professional endurance cyclists. Int J Sports Med 2006 27 880-884
24. MacArthur DG, North KN. ACTN3: A genetic influence on muscle function and athletic performance. Exerc Sport Sci Rev 2007 35 30-34
25. Matsakas A, Diel P. The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis. Int J Sports Med 2005 26 83-89
26. Mills M, Tang R, Weinberger R, Vander Woude DL, Beggs AH, Easteal S, North K. Differential expression of the actin-binding proteins, -actinin-2 and -3, in different species: implications for the evolution of functional redundancy. Hum Mol Gen 2001 10 1335-1346
27. Mougios V. Reference intervals for serum creatine kinase in athletes. Br J Sports Med 2007 41 674-678
28. Morisaki T, Gross M, Morisaki H, Pongrats D, Zöllinger N, Holmes EW. Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci USA 1992 89 6457-6461
29. NCI-NHGRI Working Group on Replication in Association Studies (Chanock SJ, Manolio T, Boehnke M, et al.). Replicating genotype-phenotype associations. Nature 2007 447 655-660
30. Newman MA, Tarpenning KM, Marino FE. Relationships between isokinetic knee strength, single-sprint performance, and repeated-sprint ability in football players. J Strength Cond Res 2004 18 867-872
31. Norman B, Glenmark B, Jansson E. Muscle AMP deaminase deficiency in 2% of healthy population. Muscle Nerve 1995 18 239-241
32. Rankinen T, Wolfarth B, Simoneau J-A, Maier L-D, Rauramaa R, Rivera MA, Boulay MR, Chagnon YC, Pérusse L, Keul J, Bouchard C. No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status. J Appl Physiol 2000 88 1571-1575
33. Reilly T, Thomas V. A motion analysis of work-rate in different positional roles in professional football match-play. J Human Mov Stud 1976 2 87-97
34. Rico-Sanz J, Rankinen T, Joanisse DR, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family study. Physiol Genomics 2003 14 161-166
35. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990 86 1343-1346
36. Rubio JC, Martin MA, Rabadan M, San Juan AF, Alonso JM, Chicharro JL, Pérez M, Arenas J, Lucia A. Frequency of the C34T mutation of the AMPD1 gene in World-class endurance athletes -does this mutation impair performance? J Appl Physiol 2005 98 2108-2112
37. Santiago C, González-Freire M, Serratosa L, Morate FJ, Meyer T, Gómez-Gallego F, Lucia A. ACTN3 genotype in professional soccer players. Br J Sports Med 2008 42 71-73
38. Saunders MA, Good JM, Lawrence EC, Ferell RE, Li WH, Nachman MW. Human adaptive evolution at Myostatin (GDF8), a regulator of muscle growth. Am J Hum Genet 2006 79 1089-1097
39. Seibert MJ, Xue QL, Fried LP, Walston JD. Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women's Health and Aging Study II cohort. J Am Geriatr Soc 2001 49 1093-1096
40. Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJl. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004 350 2682-2688
41. Shephard RJ. Biology and medicine of soccer: an update. J Sports Sci 1999 17 757-786
42. Tarnopolsky MA, Parise G, Gibala MJ, Graham TE, Rush JW. Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans. J Physiol 2001 533 881-889
43. Tumilty D. Physiological characteristics of elite soccer players. Sports Med 1993 16 80-96
44. Williams AG, Rayson MP, Jubb M, World M, Woods DR, Hayward M, Martin J, Humphries SE, Montgomery HE. The ACE gene and muscle performance. Nature 2000 403 614
45. Withers RT, Maricic Z, Wasilewski S, Kelly L. Match analyses of Australian professional soccer players. J Human Mov Stud 1982 8 159-176
46. Yamin C, Amir O, Sagiv M, Attias E, Meckel Y, Eynon N, Sagiv M, Amir RE. ACE ID genotype affects blood creatine kinase response to eccentric exercise. J Appl Physiol 2007 103 2057-2061
47. Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, Easteal S, North K. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 2003 73 627-631